Adult Patients
Showing 17–30 of 30 results
-
Hypertriglyceridemia Trial
Be part of our research to develop better Hypertriglyceridemia treatments. Your involvement can help improve triglyceride level management. Criteria & Qualifications: • Diagnosed with Hypertriglyceridemia (HTG) and triglyceride levels between 150–499 mg/dL. • 18 years or older and able to provide consent. • Willing to follow a low-fat diet during the study. Compensation: Contact us for more information
Hypertriglyceridemia Trial
Read more -
Inflammatory Bowel Disease
Join us in advancing the understanding of treatments for IBD. Help researchers evaluate the safety and effectiveness of approved therapies for Crohn’s disease and Ulcerative Colitis. Criteria & Qualifications: • 18 years or older. • Diagnosed with Crohn’s disease or Ulcerative Colitis. • Currently using or recently started an approved treatment for IBD. Compensation: Contact us for more information
Inflammatory Bowel Disease
Read more -
NASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis. • Cannot join if you have other liver diseases or a history of chronic alcohol use. Compensation: Contact us for more information
NASH
Read more -
NASH/MASH
Help us improve treatment options for people with NASH and related health conditions. This clinical trial is studying a once-monthly therapy to reduce liver fat and improve metabolic health in diverse populations. Criteria & Qualifications: • Adults diagnosed with NASH. • Includes people with pre-diabetes or type 2 diabetes. • Open to individuals seeking better liver and metabolic health management. Compensation: Contact us for more information
NASH/MASH
Read more -
NASH/MASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH. Criteria & Qualifications: • Is at least 18 years of age or older. • Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH). • Must be weight stable for 6 months. Compensation: Up to $3,000.
NASH/MASH Study
Read more -
NASH/MASH Trial
NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with Ulcerative Colitis. • Is willing to provide medical records. Compensation: Contact us for more information.
NASH/MASH Trial
Read more -
Obesity
We are conducting a clinical study to evaluate the safety and tolerability of new health interventions. Your participation will help researchers gain valuable insights into improving treatments and overall well-being. Criteria & Qualifications: • Ages 18 to 65 years old. • BMI between 30 and 40 kg/m². • Non-pregnant females only. Compensation: Contact us for more information
Obesity
Read more -
Obesity Trial
Join a clinical trial that aims to improve health outcomes for people living with obesity or being overweight. This study is testing a new medication to see how it can reduce health risks and improve the overall quality of life for individuals managing obesity. Criteria & Qualifications: • Must be 18 years or older. • Living with obesity or overweight. • Not currently taking medications for weight loss. Compensation: Contact us for more information
Obesity Trial
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with acute RSV infection. • Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions. Compensation: Contact us for more information
Respiratory Syncytial Virus (RSV)
Read more -
Solid Tumor
Support groundbreaking research by participating in our Solid Tumor study. Your involvement could help develop innovative treatments and improve cancer care.
Criteria & Qualifications: • Diagnosed with cancer and not responding to therapy.
• Aged 18 or older, able to give consent.
• Committed to attend all study visits.
Compensation: Contact us for more informationSolid Tumor
Read more -
Thyroid Eye Disease
Join our study to explore innovative treatments for Thyroid Eye Disease. Your participation could help improve outcomes and advance research in eye health. Criteria & Qualifications: • Diagnosed with Thyroid Eye Disease. • At least 18 years old, able to consent. • Able to attend all required study visits. Compensation: Contact us for more information
Thyroid Eye Disease
Read more -
Ulcerative Colitis
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis. Criteria & Qualifications: • Is at least 18 years of age or older. • Diagnosed with Ulcerative colitis in the last 3 months. • Is willing to provide medical records. • Must have active symptoms, such as rectal bleeding. Compensation: up to $1,500
Ulcerative Colitis
Read more -
Ulcerative Colitis Clinical Trial
Ulcerative Colitis, a form of Inflammatory Bowel Disease (IBD), leads to inflammation, ulcers, and stomach discomfort. We are currently running a clinical study to test the effectiveness and safety of a new Alfa Induction Therapy for individuals suffering from Ulcerative Colitis. Criteria & Qualifications: • Must be 18 years old or above. • Recently diagnosed with Ulcerative Colitis within the past 3 months. • Agreeable to submit medical history documentation. Compensation: Contact us for more information
Ulcerative Colitis Clinical Trial
Read more -
Ulcerative Colitis Trial
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis. Criteria & Qualifications: • Is at least 16 years of age or older. • Is willing to provide medical records. • Must have active symptoms, such as rectal bleeding. Compensation: Contact us for more information
Ulcerative Colitis Trial
Read more